In our study, in subjects prone to atherosclerosis but in a stable phase of the process as the type 2 diabetic patients studied, a significant increase of the Th2-profile-related IL-4 was observed whereas we did not evidence a reduction in circulating IFN-γ during treatment. This evidence concerns the gene IL4 and atherosclerosis.